Read more about UK variant more transmissible, but does not raise severity: Lancet studies on Business Standard. The novel coronavirus variant first identified in the UK is not associated with more severe illness and death: studies
914
New Delhi, April 13
The novel coronavirus variant first identified in the UK is not associated with more severe illness and death, but appears to lead to higher viral load which makes it more transmissible, suggests an observational study.
The study of patients in London hospitals is consistent with emerging evidence that this lineage is more transmissible than the original COVID-19 strain.
A separate observational study using data logged by 37,000 UK users of a self-reporting COVID-19 symptom app found no evidence that the B.1.1.7. variant altered symptoms or likelihood of experiencing long COVID.
Authors of both studies acknowledge that these findings differ from some other studies exploring the severity of the B.1.1.7. variant and call for more research and ongoing monitoring of COVID-19 variants.
People infected with the B117 variant of the coronavirus did not experience more severe illness and were not more likely to die, according to a new study published in The Lancet Infectious Diseases.However, the strain, popularly called as the .
LONDON: New studies suggest that the UK variant of COVID-19 does not increase the chances of death, serious illness or “long COVID.”
Research in The Lancet Infectious Diseases and The Lancet Public Health used data from symptom reports made by 37,000 people to a virus-tracking mobile app and information from patients in hospital.
The first study assessed COVID-19 patients admitted to University College London Hospital and North Middlesex University Hospital between Nov. 9 and Dec. 20.
Scientists compared 198 patients with the UK variant and 143 with other COVID-19 strains. They found that 36 percent of UK-variant patients became severely ill or died, compared with 38 percent of those with other strains.